Modeling of Aryl Hydrocarbon Receptor Pathway Intrinsic Immunometabolic Role using Glioblastoma Stem Cells and Patient-Derived Organoids
Authors:
- Fumihiro WatanabeFWFumihiro Watanabe
- Ethan W. HollingsworthEHEthan W. Hollingsworth
- Jenna M. BartleyJBJenna M. Bartley
- Steven T. SizemoreSSSteven T. Sizemore
- Lianbo YuLYLianbo Yu
- Maciej PietrzakMPMaciej Pietrzak
- Paula SchiapparelliPSPaula Schiapparelli
- Vinay PuduvalliVPVinay Puduvalli
- Balveen KaurBalveen Kaur
- Alfredo Quiñones-HinojosaAQAlfredo Quiñones-Hinojosa
- Jaime ImitolaJIJaime Imitola
Preprint
Abstract
The intrinsic genetic program of glioblastoma (GBM) stem cells is critical for tumor evolution and recurrence. We recently identified intrinsic phenotypes and immune-like genetic programs of GBM organoids (GBMO) 1 from patient derived glioblastoma stem cells (GSCs), replicating genomic, metabolic, and cellular aspects of GBM in vivo . Aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, is a key regulator of infiltrating immune cells in gliomas 2, 3 and associated with poor prognosis, but its role in GSC biology is unknown 2 . Here, we show that AHR is a patient-specific regulator of the glioma intrinsic gene program in GSCs and GSC-derived GBMO that are enriched for AHR. We find that AHR is required for GSC self-renewal, GBMO expansion, radial glia-like cell proliferation, and expression of immune mediators seen in the mesenchymal subtype. CRISPR-Cas9 genetic ablation and pharmacological inhibition revealed that AHR regulates genes linked to intrinsic immunity, proliferation, and migration in GBMO. Genomic analysis of GBMO treated with AHR inhibitors identified expression signatures and candidate markers associated with survival of gliomas. Our work defines the glioma intrinsic function of AHR in a model of early GBM formation, offering a rationale for clinical exploration of a potential ‘two-hit’ target of both GBM cells and infiltrating immune cells in patients with GBM expressing high levels of AHR.Keywords
This publication has 54 references indexed in Scilit:
- Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3Proceedings of the National Academy of Sciences, 2013
- InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curationNucleic Acids Research, 2012
- Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activationProceedings of the National Academy of Sciences, 2012
- Novel cancer immunotherapy agents with survival benefit: recent successes and next stepsNature Reviews Cancer, 2011
- On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival dataStatistics in Medicine, 2011
- Reversible neural stem cell niche dysfunction in a model of multiple sclerosisAnnals of Neurology, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Persistent inflammation alters the function of the endogenous brain stem cell compartmentBrain, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005